Non Serious Adverse Drug Reactions Report

Start Date:2016-04-01 End Date:2016-04-04
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0174Subject Initials :YXCDOB :06/04/2015Sex:FemaleRace:AsianHeight:155cmWeight:54.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/12/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopic surgery: left ovarian endometriosis cystectomyUk-Unk-2010Not on treatment/medication
HSG: the left fallopian tube obstruction, right fallopian tube inflammation.Uk-Unk-2012Not on treatment/medication
Laparoscopic surgery: pelvic adhesions dissection, left fallopian tube plastic surgeryUk-Unk-2012Not on treatment/medication
 



01-APR-16
NA/EMR700623-541/C02-0174
Page 1 of 6
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-01 End Date:2016-04-04
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0175Subject Initials :L-TDOB :02/15/1989Sex:FemaleRace:AsianHeight:158cmWeight:40.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/11/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal obstruction. Uk-Aug-2014Not on treatment/medication
Laparoscopy surgery: pelvic adhesions dissection, tubal plastic surgery to repair the left corpus luteum cyst cystectomy,Uk-Unk-2014Not on treatment/medication
 



01-APR-16
NA/EMR700623-541/C02-0175
Page 2 of 6
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-01 End Date:2016-04-04
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0176Subject Initials :KBFDOB :05/19/1986Sex:FemaleRace:AsianHeight:160cmWeight:57.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment05/27/2015200
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS06/11/201506/16/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Tubal examination: passableUk-Unk-2008Not on treatment/medication
HSG: bilateral tubal occlusionUk-Unk-2009Not on treatment/medication
Laparoscopy surgery: bilateral tubal repair plastic surgery, pelvic adhesions dissectionUk-Unk-2011Not on treatment/medication
Ectopic pregnancy: open surgeryUk-Unk-2012Not on treatment/medication
 



01-APR-16
NA/EMR700623-541/C02-0176
Page 3 of 6